Sagimet Biosciences Inc.SGMTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-45.65M
↓ 79% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-25.57M
Historical baseline
PeriodValueYoY Change
2025$-45.65M-7.6%
2024$-42.44M-78.6%
2023$-23.77M+3.0%
2022$-24.49M-12.8%
2021$-21.71M-108.4%
2020$-10.42M+1.3%
2019$-10.55M-